PUBLISHER: Grand View Research | PRODUCT CODE: 2132587
PUBLISHER: Grand View Research | PRODUCT CODE: 2132587
The North America healthcare disinfectant wipes market size was valued at USD 667.3 million in 2025 and is projected to grow from USD 704.2 million in 2026 to USD 1,026.5 million by 2033, at a CAGR of 5.5% from 2026 to 2033. The market growth is driven by the increasing emphasis on healthcare-associated infection (HAI) prevention, stringent infection control regulations, growing adoption of ready-to-use disinfectants across healthcare facilities, rising demand for faster-acting, broad-spectrum disinfectant chemistries, and continuous innovation in sustainable, high-performance wipe technologies.
The North America healthcare disinfectant wipes industry is witnessing steady growth as healthcare providers intensify environmental cleaning protocols to reduce the transmission of healthcare-associated infections (HAIs) and multidrug-resistant organisms (MDROs). Hospitals, ambulatory surgery centers, long-term care facilities, and outpatient clinics are increasingly adopting pre-saturated disinfectant wipes because they offer standardized disinfectant dosing, shorter contact times, improved workflow efficiency, and reduced cross-contamination compared to reusable cloth-based cleaning systems. The growing prevalence of pathogens such as Candida auris, Clostridioides difficile (C. difficile), methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant enterococci (VRE) has further accelerated the use of EPA-registered disinfectant wipes capable of meeting stringent infection prevention requirements. Additionally, increasing procedural volumes and higher patient throughput across healthcare settings continue to drive routine consumption of surface disinfectant wipes.
The market is also benefiting from continuous innovation in disinfectant chemistries and wipe substrates. Manufacturers are increasingly introducing accelerated hydrogen peroxide, improved alcohol-based, and next-generation quaternary ammonium formulations that provide broader antimicrobial efficacy, shorter kill times, reduced residue, and enhanced compatibility with sensitive medical equipment. At the same time, healthcare systems are seeking products that combine infection prevention with sustainability goals, encouraging the commercialization of biodegradable, plastic-free, and refill-compatible disinfectant wipe solutions. Product development is increasingly focused on balancing clinical efficacy, user safety, equipment compatibility, and environmental performance, enabling suppliers to differentiate their offerings in a highly regulated market.
Another significant trend shaping the market is the expansion of outpatient healthcare services and the digitalization of infection prevention practices. The rapid growth of ambulatory surgery centers, urgent care clinics, dialysis centers, and physician offices has increased demand for convenient, ready-to-use disinfectant wipes that enable rapid room turnover between patients without disrupting clinical workflows. Simultaneously, healthcare organizations are strengthening compliance with standardized cleaning protocols through environmental monitoring programs, staff training, and infection prevention audits, resulting in more consistent use of disinfectant wipes across care settings. As healthcare providers continue to prioritize patient safety, regulatory compliance, and operational efficiency, disinfectant wipes are evolving from routine cleaning supplies into essential components of comprehensive infection prevention and environmental hygiene strategies.
North America Healthcare Disinfectant Wipes Market Report Segmentation
This report forecasts revenue growth at the regional & country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2026 to 2033. For this study, Grand View Research has segmented the North America healthcare disinfectant wipes market report based on product, pack format, wipe count per pack, facility type, and region: